Nicotine effects on PGE2 and IL-1β release by LPS-treated human monocytes

Journal of Periodontal Research

Volumn 31, Issue 2, 1996, Pages 99-104

  Payne, J B ^a   Johnson, G K ^c   Reinhardt, R A ^a   Dyer, J K ^a   Maze, C A ^a   Dunning, D G ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

(IL 1 ); Interleukin 1 ; Lipopolysaccharide (LPS); Monocytes; Nicotine; Prostaglandin E2; Smoking, smokeless tobacco

Indexed keywords

INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NICOTINE; NICOTINIC AGENT; PROSTAGLANDIN E2;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MIDDLE AGED; MONOCYTE; OSTEOLYSIS; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; SECRETION; UPREGULATION;

ADULT; ANALYSIS OF VARIANCE; BONE RESORPTION; CELLS, CULTURED; DINOPROSTONE; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; NICOTINE; NICOTINIC AGONISTS; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; UP-REGULATION;

EID: 0030087990     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1996.tb00470.x     Document Type: Article

References (39)

1. Haber J, Kent KL. Cigarette smoking in a periodontal practice. J Periodontol 1992; 63: 100-106.
2. Grossi SG, Zambon JL, Hu AW, et al. Assessment of risk for periodontal disease I. Risk indictors for attachment loss. J Periodontol 1994: 65: 260-267.
3. Feldman RS, Bravacos JS, Rose CL. Association between smoking different tobacco products and periodontal disease indexes. J Periodontol 1983; 54: 481-487.
4. Bergstrom J, Eliasson S, Preber H. Cigarette smoking and periodontal bone loss. J Periodontol 1991; 62: 242-246.
5. Preber H, Bergstrom J. The effect of cigarette smoking on periodontal healing following surgical therapy. J Clin Periodontol 1990; 17. 324-328.
6. MacFarlane GD, Herzberg MC, Wolff LF, Hardie NA. Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking. J Periodontol 1992; 63: 908-913.
7. Newman MG, Kornman KS, Holtzman S. Association of clinical risk factors with treatment outcomes. J Periodontol 1994; 65: 489-497.
8. Ah MKB, Johnson GK, Kaldahl WB, Patil KD, Kalkwarf KL. The effect of smoking on the response to periodontal therapy. J Clin Periodontol 1994; 21: 91-97.
9. Bergstrom J, Preber H. Tobacco use as a risk factor. J Periodontol 1994; 65: 545-550.
10. Seymour GJ. Importance of the host response in the periodontium. J Clin Periodontol 1991; 18: 421-426.
11. Dzink JL, Tanner ACR, Haffajee AD, Socransky SS. Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol 1985; 12: 648-659.
12. Cuff MJA, McQuade MJ, Scheidt MJ, Sutherland DE. Van Dyke TE. The presence of nicotine on root surfaces of periodontally diseased teeth in smokers. J Periodontol 1989; 60: 564-569.
13. McGuire JR, McQuade MJ, Rossman JA, et al. Cotinine in saliva and gingival crevicular fluid of smokers with periodontal disease. J Periodontol 1989; 60: 176-181.
14. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986; 21: 101-112.
15. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin 1β from sites of active periodontal disease. J Clin Periodontol 1991; 18: 548-554.
16. Luderitz O, Freudenberg MA, Galanos C, Lehmann V. Rietschel ET, Shaw DW. Lipopolysaccharides of gram-negative bacteria. In: Razin CS, Rottem S, eds. Current topics in membranes and transport. London: Academic Press, 1982: 79-151.
17. Rosenstreich DL, Vogel SN. The central role of macrophages in endotoxin reactions. In: Schlessinger D, ed. Microbiology. Washington, D.C : American Society for Microbiology, 1980: 11-15.
18. Schifferle RE, Reddy MS, Zambon JJ, Genco RJ, Levine MJ. Characterization of a polysaccharide antigen from Bacteroides gingivalis. J Immunol 1989; 143. 3035-3042.
19. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21: 77-89.
20. Rutherford RB, Schenkein HA. C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes in vitro. J Immunol 1983; 130: 874-877.
21. Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesety C, Salloojee Y. Biochemical markers of smoke absorption and self-reported exposure to passive smoking. J Epidemiol Community Health 1984; 38: 335-339.
22. Russell MAH, Jarvis MJ, Devitt G, Feyerabend C. Nicotine intake by snuff users. Br Med J 1981; 283: 814-817.
23. Benowitz NL, Porchet H, Sheiner L, Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988; 44: 23-28.
24. Hoffmann D, Adams J. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cane Res 1981; 41: 4305-4308.
25. 2, and bile acids Scand J Gastroenterol 1993; 28: 487-494
26. Dimitriu-Bona A, Burmester GR, Waters SJ, Winchester RJ. Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surfaces of human monocytes and macrophages defined by monoclonal antibodies. J Immunol 1983; 130: 145-152.
27. Wahl LM, Lampel LL. Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs. Cell Immunol 1987; 105: 411-422.
28. Klein DC, Raisz LG. Prostaglandins. Stimulation of bone resorption in tissue culture. Endocrinology 1970; 86: 1436-1440.
29. 2 and IL-1β. J Periodontol 1994; 65: 937-941.
30. Kunkel SL, Chensue SW, Phan SH. Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 1986; 136: 186-192.
31. 2. J Dent Res 1995; 74 (Sp. Is.): 20.
32. 2, interleukin-1α, and interleukin-1β. J Periodontol 1995; 66: 177-183.
33. Offenbacher S, Weathers DR. Effects of smokeless tobacco on the periodontal, mucosal and caries status of adolescent males. J Oral Pathol 1985; 14: 162-181.
34. Ringdahl B, Ali RB, Johnson GK, Organ CC. Effect of topical nicotine on arachidonic acid metabolites and histological parameters in rat oral mucosa. J Periodontol 1994; 65: 986 (abstract).
35. Wennmalm A. Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis. Br J Pharmacol 1978; 64: 559-563.
36. Bull HA, Pittilo RM, Woolf N, Machin SJ. The effect of nicotine on human endothelial cell release of prostaglandins and ultrastructure. Br J Exp Pathol 1988, 69: 413-421.
37. Seow WK, Thong YH, Nelson RD, MacFarlane GD, Herzberg MC. Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 1994; 18: 119-127.
38. Goerig M, Ullrich V, Schettler G, Foltis C, Habenicht A. A new role for nicotine selective inhibition of thromboxane formation by direct interaction with thromboxane synthase in human promyelocytic leukaemia cells differentiating into macrophages. Clin Investig 1992; 70: 239-243.
39. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.